Key facts
- Active LCDs
- 203
- Contracts
- 7
- 15004, 15101, 15102, 15201, 15202, 17013, 18003
- States and territories
- 37
- AL AR CO DC DE FL GA IA IL IN KS KY LA MD MI MN MO MS MT NC ND NE NM OH OK PA PR SC SD TN TX UT VA VI WI WV WY
- Contractor site
- www.cgsmedicare.com/jc
Jurisdictions
Contract numbers identify the jurisdiction on remittances and in the Medicare Coverage Database; A and B MAC contracts cover both institutional and professional claims, while DME and HHH contracts are national or regional specialty jurisdictions.
| Contract | Type | States |
|---|---|---|
| 15004 | HHH MAC | CO DC DE IA KS MD MO MT ND NE PA SD UT VA WV WY |
| 15101 | MAC - Part A | KY |
| 15102 | MAC - Part B | KY |
| 15201 | MAC - Part A | OH |
| 15202 | MAC - Part B | OH |
| 17013 | DME MAC | IL IN KY MI MN OH WI |
| 18003 | DME MAC | AL AR CO FL GA LA MS NC NM OK PR SC TN TX VA VI WV |
Most recently effective LCDs
Revision effective dates signal where this contractor has tightened or loosened criteria; the ten newest are listed first, with the full list below.
| LCD | Title | Effective |
|---|---|---|
| L33317 | External Breast Prostheses | 2026-12-20 |
| L33789 | Power Mobility Devices | 2026-12-20 |
| L33792 | Wheelchair Options/Accessories | 2026-12-20 |
| L38284 | MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer | 2026-11-12 |
| L38288 | MolDX: Repeat Germline Testing | 2026-11-12 |
| L36675 | ProMark® Risk Score | 2026-11-12 |
| L40056 | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | 2026-11-05 |
| L33944 | Blepharoplasty | 2026-11-05 |
| L33946 | Capsule Opacification Following Cataract Surgery: Discission and YAG Laser Capsulotomy | 2026-11-05 |
| L33959 | Cardiac Catheterization and Coronary Angiography | 2026-11-05 |
All active LCDs (203)
80 of this contractor's policies have an indexed reference page and are linked below, most searched first. The other 123 are versions of a title another contractor also publishes, short policies or retired policies; they follow as a list and are reachable from their topic comparison pages.
- L33822 Glucose Monitors
- L33789 Power Mobility Devices
- L33318 Knee Orthoses
- L33686 Ankle-Foot/Knee-Ankle-Foot Orthosis
- L33718 Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea
- L33792 Wheelchair Options/Accessories
- L33797 Oxygen and Oxygen Equipment
- L33831 Surgical Dressings
- L33794 External Infusion Pumps
- L36690 Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities
- L33312 Wheelchair Seating
- L33370 Nebulizers
- L33641 Orthopedic Footwear
- L34823 Tumor Treatment Field Therapy (TTFT)
- L33690 Automatic External Defibrillators
- L33735 Cold Therapy
- L33737 Eye Prostheses
- L33787 Lower Limb Prostheses
- L33803 Urological Supplies
- L34062 Dialysis Access Maintenance
- L34064 Panretinal (Scatter) Laser Photocoagulation
- L38111 MolDX: Pigmented Lesion Assay
- L38303 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38992 Electroretinography (ERG)
- L39591 External Upper Limb Tremor Stimulator Therapy
- L40140 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L40224 Automated Detection and Quantification of Brain MRIs
- L33317 External Breast Prostheses
- L33369 Therapeutic Shoes for Persons with Diabetes
- L33610 Intravenous Immune Globulin
- L33611 Oral Appliances for Obstructive Sleep Apnea
- L33612 Suction Pumps
- L33642 Pressure Reducing Support Surfaces - Group 2
- L33692 Pressure Reducing Support Surfaces - Group 3
- L33733 Canes and Crutches
- L33736 Commodes
- L33739 Speech Generating Devices (SGD)
- L33784 Heating Pads and Heat Lamps
- L33785 High Frequency Chest Wall Oscillation Devices
- L33788 Manual Wheelchair Bases
- L33790 Spinal Orthoses: TLSO and LSO
- L33791 Walkers
- L33793 Refractive Lenses
- L33795 Mechanical In-exsufflation Devices
- L33796 Osteogenesis Stimulators
- L33799 Patient Lifts
- L33800 Respiratory Assist Devices
- L33801 Seat Lift Mechanisms
- L33802 Transcutaneous Electrical Nerve Stimulators (TENS)
- L33820 Hospital Beds And Accessories
- L33821 Negative Pressure Wound Therapy Pumps
- L33823 Cervical Traction Devices
- L33824 Immunosuppressive Drugs
- L33826 Oral Anticancer Drugs
- L33827 Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics)
- L33828 Ostomy Supplies
- L33830 Pressure Reducing Support Surfaces - Group 1
- L33832 Tracheostomy Care Supplies
- L33942 Physical Therapy - Home Health
- L33944 Blepharoplasty
- L33946 Capsule Opacification Following Cataract Surgery: Discission and YAG Laser Capsulotomy
- L33950 Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography
- L34008 Computerized Corneal Topography
- L34037 Flow Cytometry
- L34081 Endoscopy by Capsule
- L34084 Transcatheter Infusion Therapy
- L34085 Post-Void Residual Urine and/or Bladder Capacity by Ultrasound
- L34087 Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based
- L34090 Laser Ablation of the Prostate
- L34171 Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation
- L34353 Outpatient Psychiatry and Psychology Services
- L34539 Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians
- L34821 Transcutaneous Electrical Joint Stimulation Devices (TEJSD)
- L35986 Special Histochemical Stains and Immunohistochemical Stains
- L36267 Bowel Management Devices
- L38268 Immune Thrombocytopenia (ITP) Therapy
- L38378 Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
- L38953 Parenteral Nutrition
- L38955 Enteral Nutrition
- L39521 Positron Emission Tomography (PET) Scan for Inflammation and Infection
Show the other 123 policies
- L36485 <b> MolDX: HLA-DQB1*06:02 Testing for Narcolepsy</b>
- L40056 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40326 Allergy Diagnostic Testing
- L39434 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39575 Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39840 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L33943 B-type Natriuretic Peptide (BNP) Testing
- L36975 Bladder/Urothelial Tumor Markers
- L36460 Bone Mass Measurement
- L39857 Botulinum Toxin Injections
- L33959 Cardiac Catheterization and Coronary Angiography
- L33947 Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA)
- L33960 Cardiovascular Nuclear Medicine
- L33954 Cataract Extraction
- L33945 Cerumen (Earwax) Removal
- L39741 Cervical Fusion
- L37254 Chiropractic Services
- L37126 Coenzyme Q10 (CoQ10)
- L38777 Colon Capsule Endoscopy (CCE)
- L34005 Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy
- L38694 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L33999 Corneal Pachymetry
- L39506 Cosmetic and Reconstructive Surgery
- L37598 Cystatin C Measurement
- L34032 Debridement Services
- L39015 Epidural Steroid Injections for Pain Management
- L34356 Erythropoiesis Stimulating Agents (ESA)
- L38773 Facet Joint Interventions for Pain Management
- L33738 Facial Prostheses
- L37575 Frequency of Hemodialysis
- L36906 GlycoMark® Testing for Glycemic Control
- L34538 Hospice Determining Terminal Status
- L38307 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38662 Implantable Continuous Glucose Monitors (I-CGM)
- L33825 Infrared Heating Pad Systems
- L39958 Intervertebral Disc Repair
- L33786 Intrapulmonary Percussive Ventilation System
- L35891 Intravenous Immune Globulin
- L37608 MDS FISH
- L37578 Micro-Invasive Glaucoma Surgery (MIGS)
- L39802 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
- L34195 Mohs Micrographic Surgery
- L40199 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L36139 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L38249 MolDX: Blood Product Molecular Antigen Typing
- L36425 MolDX: Breast Cancer Assay: Prosigna®
- L37832 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37130 MolDX: DecisionDx-UM (Uveal Melanoma)
- L37356 MolDX: EndoPredict Breast Cancer Gene Expression Test
- L37905 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L39648 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L40259 MolDX: Genetic Testing for Hereditary Thrombophilia
- L39938 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L37903 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L39017 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L36113 MolDX: MGMT Promoter Methylation Analysis
- L38016 MolDX: Melanoma Risk Stratification Molecular Testing
- L38822 MolDX: Minimal Residual Disease Testing for Cancer
- L39389 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39585 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39427 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39658 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L38997 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L36021 MolDX: Molecular Diagnostic Tests (MDT)
- L39038 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39276 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39940 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39650 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L35442 MolDX: NRAS Genetic Testing
- L38070 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38067 MolDX: Next-Generation Sequencing for Solid Tumors
- L40226 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L40000 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L36951 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L38394 MolDX: Pharmacogenomics Testing
- L38584 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- L38065 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L38284 MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer
- L38586 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L37352 MolDX: Prometheus IBD sgi Diagnostic® Policy
- L38288 MolDX: Repeat Germline Testing
- L35249 Nerve Blocks for Peripheral Neuropathy
- L35897 Nerve Conduction Studies and Electromyography
- L38771 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L34045 Non-Invasive Vascular Studies
- L34393 Ocular Photography - External
- L38920 Off-label Use of Rituximab and Rituximab Biosimilars
- L34175 Ophthalmic Angiography (Fluorescein and Indocyanine Green)
- L34181 Ophthalmic Biometry for Intraocular Lens Power Calculation
- L34399 Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
- L34049 Outpatient Physical and Occupational Therapy Services
- L38201 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L40261 Peripheral Nerve Injections and Procedures for Chronic Pain
- L39023 Platelet Rich Plasma Injections for Non-Wound Injections
- L36902 Polysomnography and Other Sleep Studies
- L36675 ProMark® Risk Score
- L39284 Prostate Cancer Detection with IsoPSA®
- L36658 Proton Beam Therapy
- L34183 Psychiatric Inpatient Hospitalization
- L34196 Psychiatric Partial Hospitalization Programs
- L34063 RAST Type Tests
- L34200 Removal of Benign Skin Lesions
- L34246 Routine Foot Care and Debridement of Nails
- L39383 Sacroiliac Joint Injections and Procedures
- L34061 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L35906 Somatosensory Testing
- L34046 Speech-Language Pathology
- L34540 Stretta Procedure
- L40179 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L40244 Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
- L40232 Total Joint Arthroplasty
- L36469 Transcranial Magnetic Stimulation (TMS)
- L34337 Transesophageal Echocardiography (TEE)
- L34541 Transtelephonic Spirometry
- L34338 Transthoracic Echocardiography (TTE)
- L39656 Trigger Point Injections (TPI)
- L39616 Urinary Biomarkers for Chronic Pain Management
- L36029 Urine Drug Testing
- L34056 Urodynamics
- L34824 Vacuum Erection Devices (VED)
- L34082 Varicose Veins of the Lower Extremity, Treatment of
- L34394 Visual Fields Testing
- L33996 Vitamin D Assay Testing
Billing articles without an LCD (11)
Most billing and coding articles sit under a Local Coverage Determination, but CGS Administrators, LLC also publishes 11 current Billing and Coding Articles that no active LCD lists as a related document and that name no National Coverage Determination in the Medicare Coverage Database; 10 carry code lists. They carry billing and coding rules of their own ((descriptor licensed by AMA) (0192T 66183); ArgusM II Retinal Prosthesis System; Endometrial Hyperplasia Treatment and others), so no policy page lists them; each is listed here with its codes.
A52432: Billing and Coding: (descriptor licensed by AMA) (0192T 66183)
Billing and Coding, effective 2023-11-16 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
44 covered ICD-10-CM codes; 1 procedure code: 66183. Check a diagnosis for 66183.
First covered codes: H40.10X1 Unspecified open-angle glaucoma, mild stage; H40.10X2 Unspecified open-angle glaucoma, moderate stage; H40.10X3 Unspecified open-angle glaucoma, severe stage; H40.10X4 Unspecified open-angle glaucoma, indeterminate stage; H40.1111 Primary open-angle glaucoma, right eye, mild stage; H40.1112 Primary open-angle glaucoma, right eye, moderate stage; …
A54327: Billing and Coding: ArgusM II Retinal Prosthesis System
Billing and Coding, effective 2023-11-16 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
1 covered ICD-10-CM code; 2 procedure codes: 0100T, L8608. Check a diagnosis for 0100T.
First covered codes: H35.52 Pigmentary retinal dystrophy.
A60462: Billing and Coding: Endometrial Hyperplasia Treatment
Billing and Coding · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
7 covered ICD-10-CM codes in 2 groups; 1 procedure code: 58999. Check a diagnosis for 58999.
First covered codes: N84.0 Polyp of corpus uteri; N92.0 Excessive and frequent menstruation with regular cycle; N92.1 Excessive and frequent menstruation with irregular cycle; N92.4 Excessive bleeding in the premenopausal period; N95.0 Postmenopausal bleeding; N85.01 Benign endometrial hyperplasia; …
A58817: Billing and Coding: Influenza Diagnostic Tests
Billing and Coding, effective 2023-11-16 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
No covered diagnosis list; 10 procedure codes: 87252, 87253, 87254, 87275, 87276, 87400, 87501, 87502, 87503, 87804. Check a diagnosis for 87252.
A56885: Billing and Coding: MolDX: HLA Testing for Transplant Histocompatibility
Billing and Coding, effective 2023-11-16 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
No covered diagnosis list; 10 procedure codes: 81370, 81371, 81372, 81373, 81375, 81376, 81378, 81379, 81380, 81382. Check a diagnosis for 81370.
A57910: Billing and Coding: MolDX: Testing of Multiple Genes
Billing and Coding, effective 2026-09-17 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
No covered diagnosis list.
A52435: Billing and Coding: Osteopathic Manipulative Treatment
Billing and Coding, effective 2025-12-04 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
10 covered ICD-10-CM codes; 5 procedure codes: 98925, 98926, 98927, 98928, 98929. Check a diagnosis for 98925.
First covered codes: M99.00 Segmental and somatic dysfunction of head region; M99.01 Segmental and somatic dysfunction of cervical region; M99.02 Segmental and somatic dysfunction of thoracic region; M99.03 Segmental and somatic dysfunction of lumbar region; M99.04 Segmental and somatic dysfunction of sacral region; M99.05 Segmental and somatic dysfunction of pelvic region; …
A56083: Billing and Coding: Rezum® System for Benign Prostatic
Billing and Coding, effective 2026-08-06 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
No covered diagnosis list; 1 procedure code: 53854. Check a diagnosis for 53854.
A52437: Billing and Coding: Sentinel Lymph Node Biopsy – Medical Policy Article
Billing and Coding, effective 2025-12-04 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
No covered diagnosis list; 12 procedure codes: 38500, 38510, 38525, 38530, 38542, 38790, 38792, 38900, 78195, A4641, A4649, A9541. Check a diagnosis for 38500.
A52438: Billing and Coding: Tetanus Immunization
Billing and Coding, effective 2025-10-01 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
1,636 covered ICD-10-CM codes; 3 procedure codes: 90702, 90714, J1670. Check a diagnosis for 90702.
First covered codes: S00.01XA Abrasion of scalp, initial encounter; S00.02XA Blister (nonthermal) of scalp, initial encounter; S00.04XA External constriction of part of scalp, initial encounter; S00.05XA Superficial foreign body of scalp, initial encounter; S00.06XA Insect bite (nonvenomous) of scalp, initial encounter; S00.07XA Other superficial bite of scalp, initial encounter; …
A52470: Billing and Coding: Venipuncture Necessitating Physician’s Skill for Specimen Collection – Supplemental Instructions Article
Billing and Coding, effective 2026-08-06 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
No covered diagnosis list; 2 procedure codes: 36410, 36415. Check a diagnosis for 36410.
How to use this contractor's policies
A Local Coverage Determination applies only to claims processed by the contractor that wrote it, so the first question is which jurisdiction the rendering location falls in; the contracts table above answers that for institutional and professional claims, and durable medical equipment follows the DME MAC region instead. Each LCD states the covered indications, the documentation the record must contain and, through its companion Billing and Coding Article, the ICD-10 codes that support medical necessity and the HCPCS codes the policy edits. When a claim denies with CARC 50 and remark N115, the remark names the LCD; open it from the list above, compare the diagnosis on the claim with the article's covered list, and build the appeal on the documentation requirements rather than on the policy itself. Where this contractor has no LCD for a service and no National Coverage Determination exists, coverage is decided claim by claim under the reasonable-and-necessary standard, which is where prior authorization and pre-service review earn their keep.
Where CGS Administrators, LLC processes claims
Contacts, portal, timely filing and claim submission details for this contractor are on the CGS Administrators payer guide.
DME MAC (durable medical equipment and supplies)
For teams evaluating QuickIntell software
Where QuickIntell fits in this jurisdiction
For recurring coverage-review work in this jurisdiction, explore QuickAuth requirement checks and documentation workflows with staff oversight. Confirm the applicable policy and supported scope; this reference and the QuickIntell sales team are not the contractor's support service.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
Which states does CGS Administrators, LLC cover?
CGS Administrators, LLC holds 7 Medicare contracts (15004 HHH MAC; 15101 MAC - Part A; 15102 MAC - Part B; 15201 MAC - Part A; 15202 MAC - Part B; 17013 DME MAC; 18003 DME MAC) covering 34 states plus DC and 2 territories: AL, AR, CO, DC, DE, FL, GA, IA, IL, IN, KS, KY, LA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NM, OH, OK, PA, PR, SC, SD, TN, TX, UT, VA, VI, WI, WV, WY.
How many LCDs does CGS Administrators, LLC have?
203 Local Coverage Determinations are active in the current Medicare Coverage Database export for CGS Administrators, LLC. Each LCD applies only in that contractor's jurisdiction, so the same service can be covered differently in a neighbouring state.
What is the difference between an LCD and an NCD?
A National Coverage Determination is set by CMS and binds every contractor. A Local Coverage Determination is written by one Medicare Administrative Contractor for its jurisdiction and cannot conflict with an NCD; where no NCD exists, the LCD is the controlling policy.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file lcd.csvSHA-256 2e0eda3351aa3d47…
Disclaimer
Contractor jurisdictions and LCD lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify coverage against the current LCD text on cms.gov or the contractor site before billing. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.